Neurabot Lab logo — Neurabot Lab is digital laboratory 4.0 platform and fighting...

Neurabot Lab

Neurabot Lab is digital laboratory 4.0 platform and fighting cancer by AI technology in computational pathology

Founded 2019 Indonesia Sleman, Indonesia 10 employees Grant AI, Analytics +4

General Information

Company Name Neurabot Lab
Founded Year 2019
Location Indonesia Sleman, Indonesia +1
Employees 10
Industries AI, Analytics, Big Data +3
Funding Stage Grant
Social

Get notified when Neurabot Lab moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neurabot Lab

Neurabot Lab is a forward-thinking medical imaging laboratory 4.0 platform that leverages AI technology in computational pathology to combat cancer. Established in 2018, the company focuses on developing AI solutions for digital pathology and medical images to analyze and predict cancer. Their mission, "Decentralizing Cancer Diagnostics," underscores their commitment to overcoming human limitations through their Artificial Intelligence Platform. Neurabot Lab recently received a grant investment on 28 December 2021 from the renowned Johnson & Johnson Foundation. With their headquarters in Indonesia, Neurabot Lab is at the forefront of the Big Data and Biotechnology industries, driving innovation in medical AI data labeling software and digital image laboratory platforms. For collaboration opportunities, reach out to [email protected].

Taxonomy: medical imaging, computational pathology, digital pathology, cancer analysis, cancer prediction, medical AI, data labeling software, artificial intelligence platform, cancer diagnostics, technology, startup, innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
28 Dec 2021
Seed Round •••••• - 01 Mar 2020
Pre Seed Round •••••• 1 •••• •••• 05 Sep 2018

Neurabot Lab Alternatives & Competitors

Neurabot Lab vs

Deliver fast and accurate pathological diagnoses for prompt patient care

Seed
2 employees
Health Care
Neurabot Lab vs

Focused on Reducing Cancer Incidence Around the World

Seed
8 employees
Health Care
Neurabot Lab vs

Pioneering AI-based cancer diagnostics in pathology

Series C
97 employees
AI, Analytics

FAQ About Neurabot Lab

Neurabot Lab is digital laboratory 4.0 platform and fighting cancer by AI technology in computational pathology
Neurabot Lab was founded in 2019.
Neurabot Lab is headquartered in Sleman, Indonesia.
Neurabot Lab operates in the following industries: AI, Analytics, Big Data, Biotechnology, Health Care, Machine Learning.
Neurabot Lab has approximately 10 employees.
Neurabot Lab has completed 3 funding rounds. The latest funding stage is Grant.
Top alternatives and competitors to Neurabot Lab include DataPathology, Proteocyte AI, Ibex Medical Analytics, Maxwell Plus, Deep Lens (acquired by Paradigm). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurabot Lab and DataPathology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neurabot Lab and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy